InvestorsHub Logo

oldstocks

05/02/24 11:27 PM

#45281 RE: StocktonCA #45276

Big Pharma Company may be able to Buyout this company for $2.50- $5.00/Share buy why would they today?
They can just start loading up shares now for pennies on the dollar if they wanted.
Let them help run up this stock where it should be.

Drug companies are not buying out drug companies in 2024, or are they!

2024 Pharmaceutical Industry Mergers & Acquisitions Roundup

Ampersand Capital Partners—Biologos LLC. ...
AstraZeneca—Fusion Pharmaceuticals. ...
Bristol Myers Squibb—Karuna Therapeutics. ...
AstraZeneca—Amolyt Pharma. ...
Novartis—IFM Due. ...
Johnson & Johnson—Ambrx. ...
Eilean Therapeutics—Ness Therapeutics. ...
CoreRx—Societal CDMO.

Is there big money in drugs?
Here are the 10 projected best-selling drugs in 2024 and their expected global sales:
Keytruda (Merck) — $27.2 billion.
Ozempic (Novo Nordisk) — $16.1 billion.
Dupixent (Sanofi) — $13.5 billion.
Eliquis (Bristol Myers Squibb) — $13.3 billion.
Biktarvy (Gilead) — $12.6 billion.
Darzalex (Johnson & Johnson) — $12 billion.

Others
https://seekingalpha.com/article/4679123-3-potential-biotech-buyout-targets-in-2024

ace65

05/03/24 9:16 AM

#45282 RE: StocktonCA #45276

Nice analogy i luv Freebird!!..This bird will fly soon.
Bullish
Bullish

LTListener

05/03/24 9:39 AM

#45284 RE: StocktonCA #45276

Well, I think their filings has continued to state they plan to license, JV/partner or sell all their assets at some point in development. There obviously is not the depth in people or money resources to go this alone. In that context, it does make the lack of 10-k and silence interesting. Have to wonder if there is some type of negotiations ongoing that places those items on the backburner.